Invex Therapeutics Ltd.ASX: IXC

Second HREC Approval for IIH EVOLVE Phase III Clinical Trial

Sep 30, 2022 at 3:12 AM UTC · Issued by Invex Therapeutics Ltd.

Invex Therapeutics Ltd has released a press release.

View Attachment